[1]Tashbayev B, Yazdani M, Arita R, et al.Intense pulsed light treatment in meibomian gland dysfunction:A concise review[J]. Ocul Surf, 2020, 18(4):583-594.
[2]Cheng SN, Jiang FG, Chen H, et al.Intense Pulsed Light Therapy for Patients with Meibomian Gland Dysfunction and Ocular Demodex Infestation[J]. Curr Med Sci, 2019,39(5):800-809.
[3]胡晓丹, 吕会斌, 江晓丹, 等.睑板腺功能障碍与睑板脂质改变[J]. 中华眼科杂志, 2015,51(3):225-229.
[4]Borchman D, Ramasubramanian A, Foulks Gn.Human Meibum Cholesteryl and Wax Ester Variability With Age, Sex, and Meibomian Gland Dysfunction[J]. Invest Ophthalmol Vis Sci, 2019,60(6):2286-2293.
[5]Paranjpe V, Tan J, Nguyen J,et al.Clinical Signs of Meibomian Gland Dysfunction (MGD) Are Associated With Changes in Meibum Sphingolipid Composition[J]. Ocul Surf, 2019,17(2):318-326.
[6]薛春燕,王春红,黄振平.超声乳化人工晶体植入治疗葡萄膜炎并发白内障的临床效果[J]. 东南国防医药, 2018,20(3):229-231.
[7]Hwang JS, Lee YP, Bae SH, et al.Utility of the optical quality analysis system for decision-making in cataract surgery[J]. BMC Ophthalmol, 2018,18(1):231.
[8]Shine WE, Mcculley JP.Association of meibumoleic acid with meibomian seborrhea[J]. Cornea, 2000,19(1):72-74.
[9]饶甲环, 马煜盛, 龙洁旎,等.胆固醇酯转移蛋白抑制剂的研究进展[J]. 医学研究生学报, 2019,32(7):776- 779.
[10]Patterson M, Vogel HJ, Prenner EJ.Biophysical characterization of monofilm model systems composed of selected tear film phospholipids [J]. Biochim Biophys Acta, 2016, 1858(2):403-414.
[11]Inaba T, Tanaka Y, Tamaki S,et al.Compensatory increases in tear volume and mucin levels associated with meibomian gland dysfunction caused by stearoyl-CoA desaturase-1 deficiency[J]. Sci Rep, 2018,8(1):3358.
[12]Arita R, Itoh K, Maeda S,et al.Proposed diagnostic criteria for obstructive meibomian gland dysfunction [J]. Ophthalmology, 2009,116(11):2058-2063.
[13]Fukuoka S, Arita R. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction:a randomized clinical study[J]. Sci Rep, 2019, 9(1): 9091.
[14]Mudgil P, Borchman D, Gerlach D,et al.Sebum/Meibum Surface Film Interactions and Phase Transitional Differences[J]. Invest Ophthalmol Vis Sci, 2016,57(6):2401-2011.
[15]阮方,接英.睑板腺功能障碍的治疗进展[J]. 中华眼科杂志,2019,55(6):465-470.